🇺🇸 FDA

Intelligence Platform

Patents

Browse 591 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 9701740

Cell-penetrating anti-DNA antibodies and uses thereof inhibit DNA repair

THE UNITED STATES OF AMERICA REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS · Granted Tue Jul 11 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 06 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9694062

Plasmodium falciparum sporozoite and liver stage antigens

United States of America as represented by the Secretary of the Air Force · Granted Tue Jul 04 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 29 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9687461

Method for detecting risk factor for metabolic syndrome or hyperferritinemia

United States of America as represented by the Secretary of the Air Force · Granted Tue Jun 27 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 22 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9662306

Compositions and methods for diagnosis and treatment of metabolic syndrome

United States of America as represented by the Secretary of the Air Force · Granted Tue May 30 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 25 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9645147

Recombinant polypeptide construct comprising Plasmodium falciparum circumsporozoite protei

United States of America as represented by the Secretary of the Air Force · Granted Tue May 09 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 04 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9636515

Method of repairing age and disease immune dysfunction and cellular senescence with lympho

Advanced Neuroregenerative Therapies, LLC. · Granted Tue May 02 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 27 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9598441

Therapeutic compounds and methods

The United States of America as represented by the Department of Veteran Affairs · Granted Tue Mar 21 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 16 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9592265

Modulation of oxidative stress, inflammation, and impaired insulin sensitivity with grape

The Regents of the University of California · Granted Tue Mar 14 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9592256

Compositions and methods for tissue repair with extracellular matrices

The Regents of the University of California · Granted Tue Mar 14 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9561206

Use of heptadecanoic acid (C17:0) to detect risk of and treat hyperferritinemia and metabo

United States of America as represented by the Secretary of the Air Force · Granted Tue Feb 07 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9546151

VMAT inhibitory compounds

The United States of America as represented by the Department of Veteran Affairs · Granted Tue Jan 17 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 12 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9534007

Methods and compositions for treatment of cyanide and hydrogen sulfide toxicity

United States of America as represented by the Secretary of the Air Force · Granted Tue Jan 03 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 29 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9523079

Cardiac repair by reprogramming of cardiac fibroblasts into cardiomyocytes

The Board of Regents of the University of Texas System · Granted Tue Dec 20 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 15 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9513289

Isoform-selective inhibitors and activators of PDE3 cyclic nucleotide phosphodiesterases

The United Sates of America, as Represented by the Department of Veterans Affairs · Granted Tue Dec 06 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 01 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9511075

Targeting NCCA-ATP channel for organ protection following ischemic episode

The United States of America as Represented by the Dept. of Veterans Affairs · Granted Tue Dec 06 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 01 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9506922

Methods for producing an immune response to tuberculosis

United States Government as represented by the Department of Veterans Affairs · Granted Tue Nov 29 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 24 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9493482

Compounds and methods for preventing or treating sensory hair cell death

Oricula Therapeutics LLC · Granted Tue Nov 15 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 10 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9464135

Epithelial membrane protein-2 (EMP2) and proliferative vitroretinopathy (PVR)

THE UNITED STATES OF AMERICA DEPARTMENT OF VETERAN AFFAIRS · Granted Tue Oct 11 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 06 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9458086

Compositions and methods for adipocyte modulation

The United States of America as Represented by the Department of Veterans Affairs Office of General Counsel—PSG IV (024) · Granted Tue Oct 04 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 29 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9457052

Allograft tolerance induction

United States of America as represented by the Secretary of the Air Force · Granted Tue Oct 04 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 29 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9458215

Compositions and methods for osteogenic gene therapy

The United States of America as represented by the Department of Veteran Affairs · Granted Tue Oct 04 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 29 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9427469

Soluble physiological chitosan formulations combined with platelet-rich plasma (PRP) for t

ORTHO REGENERATIVE TECHNOLOGIES INC. · Granted Tue Aug 30 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 25 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9402876

Method and pharmaceutical composition for hair growth

The Regents of the University of California · Granted Tue Aug 02 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9403778

Agents that prevent or repair skin damage

Regents of the University of Minnesota · Granted Tue Aug 02 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted